Lankford, Cassidy, Colleagues Launch Investigation into Abortion Drug Manufacturers, Urge FDA to Crack Down on Illegal Online Sellers

WASHINGTON, DC - US Senators James Lankford (R-OK), Chair of the Senate Values Action Team, Bill Cassidy, M.D. (R-LA), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, Steve Daines (R-MT), Cindy Hyde-Smith (R-MS), and Lindsey Graham (R-SC) began an investigation into chemical abortion drug manufacturer compliance with US Food and Drug Administration (FDA)-mandated safeguards associated with marketing their drugs. The senators also urged the FDA to leverage its authorities to combat the illegal sale of unapproved and misbranded chemical abortion drugs into the US by online entities.

"Chemical abortion drugs are being sold online with little oversight, putting women at risk and ending innocent lives," said Lankford. "The FDA must enforce the law, hold manufacturers accountable and crack down on illegal distribution. Basic safeguards exist for a reason and should be reinstated."

"Chemical abortion drug makers profit off killing innocent children while putting mothers' lives at risk," said Dr. Cassidy. "These manufacturers and websites have facilitated the explosion in online sales of these harmful drugs without regard for women's health and safety while opening the door for coercion and abuse. FDA should act within its existing authorities to curb this abuse and immediately reinstate safeguards such as the in-person dispensing requirement."

Background

Previous Democrat administrations recklessly removed the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) Program requirements for reporting non-fatal adverse events and in-person dispensing to receive the chemical abortion drugs, among other important safeguards. Ending these requirements has led to horrific instances of coerced abortions and serious adverse events going untreated and undetected.

Despite these dangers, it is unclear how the three FDA-approved chemical abortion drug manufacturers, Danco, GenBioPro, and Evita, ensure that prescribers and pharmacies comply with the few remaining REMS requirements, especially when pills are sold online and without the in-person oversight of a medical professional.

Additionally, various types of domestic and international websites appear to illegally sell unapproved and misbranded chemical abortion drugs directly to U.S. consumers, often with no prescription, no medical oversight, and no assurances on whether the drug is actually what the seller claims it is. As it did under the first Trump administration, FDA must use all of the tools at its disposal to protect women and children.

You can read the full letter to Danco HERE.

You can read the full letter to GenBioPro HERE.

You can read the full letter to Evita HERE.

You can read the full letter to FDA HERE.

###